Join us in Barcelona October 24-27, 2021
Now Accepting Abstracts
We are now accepting abstract proposals for consideration for symposia, poster, and oral presentation.
IASR/AFSP International Summit on Suicide Research
October 24-37, 2021 • Barcelona, Spain
Suicide Research and Prevention Without Borders
The Summit is sponsored by the International Academy of Suicide Research in partnership with the American Foundation for Suicide Prevention. The 2019 Summit included over 450 researchers and clinicians from 28 countries across the globe.
John Mann, M.D.
Columbia University & New York State Psychiatric Institute, USA
Ping Qin, M.D., Ph.D.
National Centre for Suicide Research and Prevention, University of Oslo, Norway
GENERAL EVENT INFORMATION
This meeting will bring together suicide researchers studying topics ranging from neurobiology, epidemiology and genetics to assessment, intervention and prevention. All suicide researchers and those interested in learning about the most cutting-edge evidence are invited to attend and take advantage of this excellent opportunity to network and interact. In addition to plenary sessions with preeminent suicide researchers and symposia, the meeting will include a mentoring program, poster sessions, and workshops addressing methodological issues particular to suicide research. Workshops will cover topics such as assessment of suicidal behavior and risk, strategies for research on low base rate outcomes, use of technology and proxy measures, approaches to facilitate inclusion of underrepresented populations, study design options that produce robust and reliable results, and guidance for the safe inclusion of individuals at high-risk for suicidal behavior.
- Participants will be able to articulate the key findings in the development of preventive, intervention, and implementation strategies and how to incorporate translational research strategies into preventive, intervention, and implementation research on suicide.
- Participants will be able to describe methodological and ethical challenges in research design for studies where the outcome of interest is suicidal ideation and behavior.
- Participants will be able to enumerate the most recent neurobiological, genetic, psychological and social evidence related to suicidal behavior.
NEEDS STATEMENT AND EDUCATIONAL GAP
As with other areas of psychiatric, epidemiological and intervention research, best practice in suicide research is based on following a generally accepted research design that incorporates the latest evidence in the area being studied and complying with IRB requirements where appropriate. However, the field of suicidology research faces unique challenges for study design. Suicide is a complex behavior resulting from the interaction of biological, psychological and social factors that must be considered in the design, conduct, and interpretation of research studies. In addition, there are unique features of suicide research including the study of low-frequency outcomes and high-risk patients, ethical choices that must trump research design, and in some situations the use of proxy outcome measures. These and many other design issues specific to suicide research require attention.
It is estimated that each year at least 800,000 people die by suicide world-wide and that for every suicide there are between 25 to 50 suicide attempts. In an effort to facilitate the development of empirically-supported approaches to the prevention of suicide and suicidal behavior, both with a focus on high risk individuals as well as populations more broadly, education of researchers and support of their work is essential. It is crucial that professionals interested in undertaking suicide research be educated about the newest developments regarding identifying risk and protective factors and the robust design and testing of effective prevention strategies. Research and its translation into clinical practice is crucial at this time because suicide rates have increased steadily in many countries in recent decades, making prevention of suicidal behavior morbidity and mortality a world-wide imperative.